DK2332986T3 - Antistof som binder til H-1 parvovirus - Google Patents

Antistof som binder til H-1 parvovirus

Info

Publication number
DK2332986T3
DK2332986T3 DK09015373.5T DK09015373T DK2332986T3 DK 2332986 T3 DK2332986 T3 DK 2332986T3 DK 09015373 T DK09015373 T DK 09015373T DK 2332986 T3 DK2332986 T3 DK 2332986T3
Authority
DK
Denmark
Prior art keywords
parvovirus
binds
antibody
Prior art date
Application number
DK09015373.5T
Other languages
English (en)
Inventor
Barbara Leuchs
Kathrin Kuerschner
Andrea Kern
Marcus Mueller
Silvia Muensterman
Jean Rommelaere
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK2332986T3 publication Critical patent/DK2332986T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/015Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
DK09015373.5T 2009-12-11 2009-12-11 Antistof som binder til H-1 parvovirus DK2332986T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09015373.5A EP2332986B1 (en) 2009-12-11 2009-12-11 Antibody that binds to H-1 parvovirus

Publications (1)

Publication Number Publication Date
DK2332986T3 true DK2332986T3 (da) 2013-12-16

Family

ID=42072902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09015373.5T DK2332986T3 (da) 2009-12-11 2009-12-11 Antistof som binder til H-1 parvovirus

Country Status (8)

Country Link
US (1) US8828400B2 (da)
EP (2) EP2332986B1 (da)
JP (1) JP5755239B2 (da)
AU (1) AU2010330349B2 (da)
CA (1) CA2781796C (da)
DK (1) DK2332986T3 (da)
ES (1) ES2438774T3 (da)
WO (1) WO2011069614A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2451844T3 (da) 2009-07-10 2015-07-27 Innate Pharma Tlr3-bindingsmidler
ES2438774T3 (es) * 2009-12-11 2014-01-20 Deutsches Krebsforschungszentrum Anticuerpo que se une a parvovirus H-1
MX361773B (es) 2012-05-31 2018-12-17 Innate Pharma Agentes de ligación a tlr3.
EP3108892A1 (en) * 2015-06-23 2016-12-28 Deutsches Krebsforschungszentrum Parvovirus formulation for treating tumors
WO2016206807A1 (en) 2015-06-23 2016-12-29 Deutsches Krebsforschungszentrum Method for large scale production and purification of parvovirus
CN109627331B (zh) * 2019-01-22 2022-03-29 长春西诺生物科技有限公司 一种抗犬细小病毒抗体的重链、轻链可变区及基因工程抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010294A1 (en) 1992-10-23 1994-05-11 New York University Human monoclonal antibodies to human parvovirus and methods of making and using thereof
ES2438774T3 (es) * 2009-12-11 2014-01-20 Deutsches Krebsforschungszentrum Anticuerpo que se une a parvovirus H-1

Also Published As

Publication number Publication date
US8828400B2 (en) 2014-09-09
AU2010330349A1 (en) 2012-06-28
CA2781796C (en) 2016-02-02
EP2509998A1 (en) 2012-10-17
EP2332986B1 (en) 2013-10-09
WO2011069614A1 (en) 2011-06-16
JP2013513358A (ja) 2013-04-22
ES2438774T3 (es) 2014-01-20
US20130028913A1 (en) 2013-01-31
CA2781796A1 (en) 2011-06-16
EP2332986A1 (en) 2011-06-15
AU2010330349B2 (en) 2013-09-19
JP5755239B2 (ja) 2015-07-29

Similar Documents

Publication Publication Date Title
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
LTC2579894I2 (lt) CGRP antikūnai
SMT201700083B (it) Anticorpi monoclonali
BRPI0907237A2 (pt) Anticorpo anti-cldn6
BRPI0923359A2 (pt) Anticorpos anti-igf
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
BRPI0916973A2 (pt) anticorpos para ccr2
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
BRPI1011005A2 (pt) anticorpos anti-epcam
CO7020875A2 (es) Anticuerpos humanizados que reconocen la alfa-sinucleina
BRPI0917204A2 (pt) variantes estruturais de anticorpos para melhores características terapêuticas
BR112012030311A2 (pt) anticorpo
CR20170001A (es) Anticuerpos anti factor d humanizados
BR112013016917A2 (pt) ligantes que ligam receptor de tgf-beta ii.
BRPI0819165A2 (pt) Anticorpos anti-vegf
BRPI1011145A2 (pt) anticorpo anti-axl
BRPI1010297A2 (pt) anticorpos biespecíficos trivalentes.
BRPI0914763A2 (pt) composição aglutinante
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
BRPI0814111A2 (pt) Anticorpo monoclonal citotóxico anticâncer
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0817427A2 (pt) Anticorpo anti-bst2
DK3360571T3 (da) Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid
BRPI0909633A2 (pt) anticorpos anti-tyrp1
DE112010000691A5 (de) Chromatographievorrichtung